Showing results (1-10 of 360) with videos related to
Sort By:
Pageof 36
Journal of Clinical Gastroenterology|May 15, 2026
Fecal Calprotectin as a Biomarker for Disease Activity in Microscopic ColitisAlexa N Sasson, Ashwin N AnanthakrishnanDigestive Diseases and Sciences|June 12, 2021
High Anti-Infliximab Antibody Titers Do Not Impact Response to Subsequent Adalimumab Treatment in Inflammatory Bowel DiseasesAlexa N Sasson, Ashwin N AnanthakrishnanClinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 9, 2019
Diet in Treatment of Inflammatory Bowel DiseasesAlexa N Sasson, Ashwin N Ananthakrishnan, Maitreyi RamanInflammatory Bowel Diseases|February 8, 2022
Fecal Calprotectin Is a Predictor of Need for Rescue Therapy in Hospitalized Severe ColitisSaranya Sasidharan, Alexa N Sasson, Kevin M Shannon, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 23, 2021
Yield and Predictors of Surveillance Colonoscopies in Older Adults With Long-standing Ulcerative ColitisAlexa N Sasson, Gabriel Sheehan, Amy Yu, et al.Clinical and Translational Gastroenterology|February 10, 2026
Dairy Intake and Risk of Incident Inflammatory Bowel Disease in US Men and WomenAlexa N Sasson, Kevin Casey, Emily W Lopes, et al.Gastroenterology & Hepatology|August 13, 2013
Environmental risk factors for inflammatory bowel diseaseAshwin N AnanthakrishnanThe American Journal of Gastroenterology|May 7, 2016
Editorial: Vitamin D and IBD: Can We Get Over the "Causation" Hump?Ashwin N AnanthakrishnanDigestive Diseases and Sciences|September 11, 2014
Environmental risk factors for inflammatory bowel diseases: a reviewAshwin N AnanthakrishnanGastroenterology Clinics of North America|April 17, 2012
Detecting and treating Clostridium difficile infections in patients with inflammatory bowel diseaseAshwin N AnanthakrishnanPageof 36